Similar articles

• Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis.

  Gertz ZM, Pibarot P, Douglas PS, Elmariah S, Alu MC, McAndrew T, Zhang Y, Hodson RW, Hahn RT, Weissman NJ, Lindman BR, Clavel MA, Lerakis S, Abbas AE, Thourani VH, Kodali S, Kapadia S, Suri RM, Makkar R, Mack M, Leon MB, Herrmann HC. Gertz ZM, et al. JACC Cardiovasc Imaging. 2019 Feb;12(2):367-368. doi: 10.1016/j.jcmg.2018.10.019. Epub 2018 Dec 12. JACC Cardiovasc Imaging. 2019. PMID: 30553688 No abstract available.
• Is cardiac hypertrophy good or bad? The answer, of course, is yes.

  Carabello BA. Carabello BA. JACC Cardiovasc Imaging. 2014 Nov;7(11):1081-3. doi: 10.1016/j.jcmg.2014.07.013. Epub 2014 Nov 10. JACC Cardiovasc Imaging. 2014. PMID: 25459588 No abstract available.
• Three-year hemodynamic performance, left ventricular mass regression, and prosthetic-patient mismatch after rapid deployment aortic valve replacement in 287 patients.

  Haverich A, Wahlers TC, Borger MA, Shrestha M, Kocher AA, Walther T, Roth M, Misfeld M, Mohr FW, Kempfert J, Dohmen PM, Schmitz C, Rahmanian P, Wiedemann D, Duhay FG, Laufer G. Haverich A, et al. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2854-60. doi: 10.1016/j.jtcvs.2014.07.049. Epub 2014 Aug 1. J Thorac Cardiovasc Surg. 2014. PMID: 25218544 Clinical Trial.
• Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications.

  Rader F, Sachdev E, Arsanjani R, Siegel RJ. Rader F, et al. Am J Med. 2015 Apr;128(4):344-52. doi: 10.1016/j.amjmed.2014.10.054. Epub 2014 Nov 25. Am J Med. 2015. PMID: 25460869 Review.
• Elucidation of cardiac physiology in aortic valve replacement: what should we know?

  Jin XY. Jin XY. J Heart Valve Dis. 2004 May;13 Suppl 1:S70-5. J Heart Valve Dis. 2004. PMID: 15225009 Review.